Partnership will provide market-tested DSCSA compliance solutions, preferential subscription pricing, streamlined implementation, and comprehensive support to ensure Value Drug pharmacy members securely meet DSCSA November 2023 deadlines at the lowest total cost of ownership.
Boston, Mass. (June 20, 2023) – TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 healthcare and life sciences entities through its B2N Integrate-OnceTM network, today announced a partnership with Value Drug Company, a leader in wholesale distribution and retail / specialty pharmacy services, to provide a comprehensive commercial, solution, and services program for independent pharmacies to meet upcoming complex DSCSA regulatory requirements which go into effect on November 27, 2023.
Rolling out at 44th Annual Expo “Solutions for Success” event on June 23rd, the preferred program for Value Drug member pharmacies will provide a tailored solution subscription and services model including:
- – Special annual subscription to TraceLink’s DSCSA compliance solution.
- – Streamlined implementation program to accelerate and simplify configuration and testing.
- – Access to TraceLink University and Healthcare Operational Support Team (HOST) programs to increase staff productivity and reduce operational and administrative burdens on pharmacy teams. Read More >
